BTOG does ... RET – this is part 3 of a series looking at mutations in lung cancer – we have already looked at BRAF and KRAS. Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Nadza Tokaca, Consultant Medical Oncologist at the Royal Marsden Hospital.